Concepedia

Naomi Dempsey

ND

7

Publications

217

Citations

7

H-Index

2015

Active since

Affiliations

University of California, San Francisco(Current)

Baptist Health South Florida

UCSF Helen Diller Family Comprehensive Cancer Center

University of Genoa

Université Paris Cité

Naomi Dempsey is an author at University of California, San Francisco specializing in oncology, medicine, and pathology.

ORCID

Top concepts

Publications per year

2015–2025

7

Publications

7

Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma

Moh’d Khushman, Naomi Dempsey, Jennifer Cudris Maldonado et al. · Pancreatology · 2015 · 80 citations

, , +8

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

Mariona Riudavets, Édouard Auclin, Miguel Mosteiro et al. · European Journal of Cancer · 2022 · 52 citations · Full text

, , +6

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

Laura A. Huppert, Reshma Mahtani, Samantha Fisch et al. · npj Breast Cancer · 2025 · 26 citations · Full text

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Édouard Auclin, José Carlos Benítez, Marco Tagliamento et al. · Lung Cancer · 2023 · 22 citations · Full text

, , +7

Abstract PS08-04: Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

Laura A. Huppert, Reshma Mahtani, Samantha Fisch et al. · Cancer Research · 2024 · 15 citations

, , +20

Rows per page

1–5 of 7